Table 1.
Antigen | Antibody | Result by exposure to malaria |
|||||
---|---|---|---|---|---|---|---|
Previous malaria episodeb |
Present infectionc |
||||||
Proportional difference | 95% CI | P value | Proportional difference | 95% CI | P value | ||
Whole P | IgG | 2.85 | 2.10–3.86 | <0.0001 | 1.84 | 1.37–2.47 | <0.0001 |
MSP-119 | IgG | 2.05 | 1.76–2.39 | <0.0001 | 1.31 | 1.14–1.51 | 0.0001 |
IgG1 | 2.56 | 2.05–3.19 | <0.0001 | 1.94 | 1.59–2.37 | <0.0001 | |
IgG2 | 1.14 | 1.06–1.23 | 0.0003 | 1.13 | 1.06–1.21 | 0.0003 | |
IgG3 | 2.31 | 1.89–2.83 | <0.0001 | 1.74 | 1.42–2.14 | <0.0001 | |
IgG4 | 1.16 | 1.10–1.23 | <0.0001 | 1.09 | 1.03–1.16 | <0.004 | |
IgM | NS | NS | NS | 1.28 | 1.11–1.48 | 0.0005 | |
AMA-1 | IgG | 1.78 | 1.54–2.05 | <0.0001 | 1.26 | 1.10–1.43 | 0.0007 |
IgG1 | 1.49 | 1.24–1.81 | <0.0001 | 1.44 | 1.22–1.71 | <0.0001 | |
IgG2 | 1.06 | 1.00–1.12 | 0.0444 | 1.10 | 1.04–1.15 | 0.0006 | |
IgG3 | 1.86 | 1.57–2.20 | <0.0001 | 1.52 | 1.28–1.82 | <0.0001 | |
IgG4 | 1.06 | 1.01–1.12 | <0.0111 | 1.09 | 1.04–1.15 | 0.0004 | |
IgM | NS | NS | NS | 1.25 | 1.12–1.39 | 0.0001 | |
EBA-175 | IgG | 1.18 | 1.06–1.31 | 0.0025 | 1.12 | 1.01–1.24 | 0.026 |
IgG1 | 1.22 | 1.00–1.49 | 0.0448 | NS | NS | NS | |
IgG2 | NS | NS | NS | NS | NS | NS | |
IgG3 | NS | NS | NS | 1.32 | 1.08–1.62 | 0.007 | |
IgG4 | NS | NS | NS | NS | NS | NS | |
IgM | NS | NS | NS | 1.15 | 1.02–1.29 | 0.023 |
Multivariate random-effect models estimated by stepwise procedure and adjusted by age and neighborhood of residence. NS, not significant in the forward stepwise procedure (P-enter = 0.05, from likelihood ratio test).
Number of children who had previous clinical episodes: 18 at 5 months, 54 at 9 months, 60 at 12 months, and 82 at 24 months.
Number of children with current parasitemia (detected by microscopy or PCR): 36 children at 5 months, 62 at 9 months, 37 at 12 months, and 78 at 24 months.